Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW274150 for Migraine Prophylaxis
NCT00242866Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing GW274150 with Placebo (2 arms). Primary endpoint: Occurrence of a migraine headache day at 12 weeks. Started Oct 2005; status: completed.
02
Drugs
GW274150
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00242866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242866.